Review
doi: 10.1016/j.bone.2006.01.141.
Epub 2006 Feb 28.
Bisphosphonate actions: physical chemistry revisited
Affiliations
- PMID: 16504613
- DOI: 10.1016/j.bone.2006.01.141
Item in Clipboard
Review
Bisphosphonate actions: physical chemistry revisited
Bone.
2006 May.
No abstract available
Similar articles
-
Current controversies in bisphosphonate therapy.Orthopedics. 2010 Jul;33(7):468. doi: 10.3928/01477447-20100526-01. Orthopedics. 2010. PMID: 20608598 No abstract available.
-
Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.Bone. 2006 May;38(5):617-27. doi: 10.1016/j.bone.2005.05.003. Epub 2005 Jul 20. Bone. 2006. PMID: 16046206
-
Bisphosphonate medications--the good, the bad, and the ugly.Tex Dent J. 2009 Jul;126(7):596-604. Tex Dent J. 2009. PMID: 19753815 Review. No abstract available.
-
Necrotic actions of nitrogen-containing bisphosphonates and their inhibition by clodronate, a non-nitrogen-containing bisphosphonate in mice: potential for utilization of clodronate as a combination drug with a nitrogen-containing bisphosphonate.Basic Clin Pharmacol Toxicol. 2009 May;104(5):384-92. doi: 10.1111/j.1742-7843.2008.00374.x. Basic Clin Pharmacol Toxicol. 2009. PMID: 19413658
-
Bisphosphonates, Old Friends of Bones and New Trends in Clinics.J Med Chem. 2021 Feb 11;64(3):1260-1282. doi: 10.1021/acs.jmedchem.0c01292. Epub 2021 Feb 1. J Med Chem. 2021. PMID: 33522236 Review.
Cited by
-
Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds.J R Soc Interface. 2010 Feb 6;7(43):209-27. doi: 10.1098/rsif.2009.0379. Epub 2009 Oct 28. J R Soc Interface. 2010. PMID: 19864265 Free PMC article. Review.
-
Cytotoxicity of the new antimetabolite-bisphosphonate (5-FdU-alendronate) in comparison to standard therapeutics on breast and ovarian cancer cell lines in the ATP tumor chemosensitivity assay.Invest New Drugs. 2012 Aug;30(4):1750-5. doi: 10.1007/s10637-011-9688-3. Epub 2011 May 21. Invest New Drugs. 2012. PMID: 21604021 No abstract available.
-
Changes in bone remodelling and antifracture efficacy of intermittent bisphosphonate therapy: implications from clinical studies with ibandronate.Ann Rheum Dis. 2007 Jul;66(7):853-8. doi: 10.1136/ard.2006.064931. Epub 2007 Feb 2. Ann Rheum Dis. 2007. PMID: 17277001 Free PMC article. Review.
-
Bone antiresorptive agents in the treatment of bone metastases associated with solid tumours or multiple myeloma.Bonekey Rep. 2015 Oct 7;4:744. doi: 10.1038/bonekey.2015.113. eCollection 2015. Bonekey Rep. 2015. PMID: 26512321 Free PMC article. Review.
-
A Review on the Molecular Mechanisms of Action of Natural Products in Preventing Bone Diseases.Int J Mol Sci. 2022 Jul 30;23(15):8468. doi: 10.3390/ijms23158468. Int J Mol Sci. 2022. PMID: 35955603 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
